Health Technology Assessments (HTA)
The Norwegian Institute of Public Health contributes to national and international Health Technology Assessments.
Reports
Projects
- Health Technology Assessment of medicines, including rituximab, used for primary progressive multiple sclerosis (PPMS)
- Safety, clinical effectiveness, diagnostic accuracy and cost effectiveness of blood-based tests for women with suspected pre-eclampsia
- Disinvestment of medical technologies in Specialist Healthcare Services
- Controlled donation after circulatory death (cDCD) using normothermic regional perfusion in patients who die after withdrawal of life sustaining treatment
- Cost effectiveness, efficacy and safety of PFO closure as compared to medical management for patients with cryptogenic ischaemic stroke
